Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases.


Journal

Magnetic resonance imaging
ISSN: 1873-5894
Titre abrégé: Magn Reson Imaging
Pays: Netherlands
ID NLM: 8214883

Informations de publication

Date de publication:
06 2020
Historique:
received: 28 12 2019
revised: 20 02 2020
accepted: 05 03 2020
pubmed: 18 3 2020
medline: 16 12 2020
entrez: 18 3 2020
Statut: ppublish

Résumé

Lung cancer metastases comprise most of all brain metastases in adults and most brain metastases are diagnosed by magnetic resonance (MR) scans. The purpose of this study was to conduct an MR imaging-based radiomic analysis of brain metastatic lesions from patients with primary lung cancer to classify mutational status of the metastatic disease. We retrospectively identified lung cancer patients with brain metastases treated at our institution between 2009 and 2017 who underwent genotype testing of their primary lung cancer. Brain MR Images were used for segmentation of enhancing tumors and peritumoral edema, and for radiomic feature extraction. The most relevant radiomic features were identified and used with clinical data to train random forest classifiers to classify the mutation status. Of 110 patients in the study cohort (mean age 57.51 ± 12.32 years; M: F = 37:73), 75 had an EGFR mutation, 21 had an ALK translocation, and 15 had a KRAS mutation. One patient had both ALK translocation and EGFR mutation. Majority of radiomic features most relevant for mutation classification were textural. Model building using both radiomic features and clinical data yielded more accurate classifications than using either alone. For classification of EGFR, ALK, and KRAS mutation status, the model built with both radiomic features and clinical data resulted in area-under-the-curve (AUC) values based on cross-validation of 0.912, 0.915, and 0.985, respectively. Our study demonstrated that MR imaging-based radiomic analysis of brain metastases in patients with primary lung cancer may be used to classify mutation status. This approach may be useful for devising treatment strategies and informing prognosis.

Identifiants

pubmed: 32179095
pii: S0730-725X(19)30774-X
doi: 10.1016/j.mri.2020.03.002
pmc: PMC7237274
mid: NIHMS1579140
pii:
doi:

Substances chimiques

KRAS protein, human 0
ALK protein, human EC 2.7.10.1
Anaplastic Lymphoma Kinase EC 2.7.10.1
EGFR protein, human EC 2.7.10.1
ErbB Receptors EC 2.7.10.1
Proto-Oncogene Proteins p21(ras) EC 3.6.5.2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

49-56

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA013330
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA033572
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA209978
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest All authors declared that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Sci Rep. 2017 Jan 31;7:41674
pubmed: 28139704
Cancer Discov. 2017 Aug;7(8):818-831
pubmed: 28572459
Med Image Anal. 2011 Apr;15(2):267-82
pubmed: 21233004
N Engl J Med. 2018 Jan 11;378(2):113-125
pubmed: 29151359
Magn Reson Med. 1999 Dec;42(6):1072-81
pubmed: 10571928
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
Eur J Cancer. 2012 Mar;48(4):441-6
pubmed: 22257792
Transl Oncol. 2018 Feb;11(1):94-101
pubmed: 29216508
Lung Cancer. 2015 Apr;88(1):108-11
pubmed: 25682925
N Engl J Med. 2015 Jul 9;373(2):123-35
pubmed: 26028407
IEEE Trans Med Imaging. 2010 Jan;29(1):196-205
pubmed: 19923044
Sci Rep. 2015 Aug 17;5:13087
pubmed: 26278466
Magn Reson Med. 2016 Nov;76(5):1410-1419
pubmed: 26621795
Handb Clin Neurol. 2018;149:3-23
pubmed: 29307359
Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:493-496
pubmed: 29059917
Radiology. 2014 Feb;270(2):320-5
pubmed: 24471381
Front Aging Neurosci. 2017 Oct 06;9:329
pubmed: 29056906
Nat Commun. 2014 Jun 03;5:4006
pubmed: 24892406
Neuroimage Clin. 2014 Aug 15;6:9-19
pubmed: 25379412
Bioinformatics. 2005 Aug 1;21(15):3301-7
pubmed: 15905277
MAGMA. 2018 Apr;31(2):285-294
pubmed: 28939952
Clin Lung Cancer. 2016 Sep;17(5):441-448.e6
pubmed: 27017476
Curr Oncol. 2013 Aug;20(4):e300-6
pubmed: 23904768
Eur Radiol. 2016 Jan;26(1):32-42
pubmed: 25956936
Neuro Oncol. 2015 Feb;17(2):296-302
pubmed: 25053852
IEEE Trans Pattern Anal Mach Intell. 2005 Aug;27(8):1226-38
pubmed: 16119262
Cureus. 2016 Feb 26;8(2):e513
pubmed: 27026837
Neuroimage. 2006 Jul 1;31(3):1116-28
pubmed: 16545965
Ther Adv Med Oncol. 2017 Dec;9(12):781-796
pubmed: 29449898
Cureus. 2016 Apr 25;8(4):e584
pubmed: 27226944

Auteurs

Bihong T Chen (BT)

Department of Diagnostic Radiology, City of Hope National Medical Center, Duarte, CA, United States. Electronic address: Bechen@coh.org.

Taihao Jin (T)

Department of Diagnostic Radiology, City of Hope National Medical Center, Duarte, CA, United States.

Ningrong Ye (N)

Department of Diagnostic Radiology, City of Hope National Medical Center, Duarte, CA, United States.

Isa Mambetsariev (I)

Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte 91010, CA, United States.

Ebenezer Daniel (E)

Department of Diagnostic Radiology, City of Hope National Medical Center, Duarte, CA, United States.

Tao Wang (T)

Departments of Interventional Radiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, PR China.

Chi Wah Wong (CW)

Applied Al and Data Science, City of Hope National Medical Center, Duarte 91010, CA, United States.

Russell C Rockne (RC)

Division of Mathematical Oncology, City of Hope National Medical Center, Duarte, CA, United States.

Rivka Colen (R)

Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, United States; Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.

Andrei I Holodny (AI)

Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY, United States.

Sagus Sampath (S)

Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA, United States.

Ravi Salgia (R)

Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte 91010, CA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH